Skip to main content

GOLDMAN SACHS GROUP INC

Position in TRVI — Trevi Therapeutics, Inc.

CIK 886982 NEW YORK, NY

Position in TRVI

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$22,426,997
+$7,779,678 QoQ
Shares Held
1,202,520
-2.1% QoQ
Ownership
0.844%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#35
of 216 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TRVI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,040,376,854 across 359 Biotechnology names. TRVI ranks #108 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in TRVI

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $22,426,997 1,202,520
2026-03-31 $14,647,319 1,227,772
2025-12-31 $13,232,274 1,056,891
2025-09-30 $7,205,203 787,454
2025-06-30 $1,635,776 299,045
2025-03-31 $1,332,680 211,873
2024-12-31 $972,913 236,144
2024-09-30 $548,554 164,238
2024-06-30 $218,115 73,193
2024-03-31 $131,010 37,974
2023-12-31 $32,046 23,915
2023-09-30 $57,007 26,150
2023-06-30 $83,771 35,051